6SM-76650-55397
3 vaccinations
6 coded responses
26 check-ins
6 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 970 / OR
- Registered
- 2021-01-02
- Relationship
- Self
- Race
- Native Hawaiian or other Pacific Islander
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-02
Registered in v-safe
-
2021-01-02
Dose 1 — Moderna
- 2021-01-02
-
2021-01-03
Survey response — days 1–6 daily, dose 1MedDRA: Pain in extremity — Feeling: GoodFree text: My arm was sore last night and is improving today.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-04
- 2021-01-05
- 2021-01-06
- 2021-01-07
- 2021-01-08
- 2021-01-09
- 2021-01-16
- 2021-01-23
-
2021-01-30
Dose 2 — Moderna
- 2021-01-30
-
2021-01-31
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
-
2021-02-05
Survey response — days 1–6 daily, dose 2MedDRA: Chemotherapy, Pre-existing disease — Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: I started a new chemo today for recurrence of ovarian cancer.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-08
- 2021-02-13
-
2021-02-20
Survey response — day 21, dose 2MedDRA: Abdominal pain — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Abdominal painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-20
Report sent to call center — day 21, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-27
Survey response — day 28, dose 2MedDRA: Condition aggravated, Metastatic lymphoma, Ovarian cancer recurrent, Positron emission tomogram abnormal, Pre-existing disease — Feeling: GoodFree text: I had a Pet scan shortly after 1st dose that showed recurrence of ovarian cancer in axillary lymph node as well as another location. Doctor now thinks lymph node is actually just due to covid vaccine.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-06
- 2021-03-13
-
2021-05-01
Survey response — 3 months, dose 2MedDRA: Pre-existing disease, Rash, Respiratory tract congestion, Rhinorrhoea — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Congestion, runny nose, rash. The hear are likely side effects of treatment with doxil & avastin for ovarian cancer recurrence.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-01
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-16
-
2021-08-02
Survey response — 6 months, dose 2MedDRA: Cough, Headache, Oropharyngeal pain, Respiratory tract congestion — Feeling: FairFree text: Sore throat, cough, congestion, headacheMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-09-03
Dose 3 — Moderna
- 2022-02-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-02 | Moderna | |
| 2 | 2021-01-30 | Moderna | |
| 3 | 2021-09-03 | Moderna | No |
Call center
2 call center cases
2 unsuccessful
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): My arm was sore last night and is improving today.
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): I started a new chemo today for recurrence of ovarian cancer.
Release 4 — day 21, dose 2
Symptoms: Abdominal pain
Release 4 — day 28, dose 2
Symptoms: I had a Pet scan shortly after 1st dose that showed recurrence of ovarian cancer in axillary lymph node as well as another location. Doctor now thinks lymph node is actually just due to covid vaccine.
Release 8 — 3 months, dose 2
Symptoms: Congestion, runny nose, rash. The hear are likely side effects of treatment with doxil & avastin for ovarian cancer recurrence.
Release 9 — 6 months, dose 2
Symptoms: Sore throat, cough, congestion, headache
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal pain | ✓ | ✓ | ✓ |
| SD | Condition aggravated | ✓ | · | ✓ |
| SD | Cough | ✓ | · | ✓ |
| SD | Headache | ✓ | · | ✓ |
| SD | Metastatic lymphoma | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | · | ✓ |
| SD | Ovarian cancer recurrent | ○ | ✓ | ○ |
| SD | Positron emission tomogram abnormal | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SRO | Chemotherapy | ✓ | ✓ | ✓ |
| SRO | Pain in extremity | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release